Xiaojing Xu
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A clinico-radiological model integrating baseline CT-derived body composition to predict prognosis in immunotherapy-treated metastatic colorectal cancer.
Journal: European journal of radiology
Published: April 21, 2026
Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study.
Journal: The oncologist
Published: July 27, 2025
Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 01, 2025
Associations of serum 25-hydroxyvitamin D with hsCRP and other novel inflammatory biomarkers in children: a cross-sectional study.
Journal: BMJ open
Published: September 06, 2024
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study.
Journal: Nature communications
Published: March 09, 2024
Serum 25 hydroxyvitamin D was positively associated with hemoglobin and other anemia parameters in children: a cross-sectional study.
Journal: Nutrition & metabolism
Published: January 05, 2024
Prediction values of fat-soluble vitamin of growth retardation in children aged 1-6 years.
Journal: Frontiers in pediatrics
Published: October 23, 2023
Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 08, 2022
Toripalimab in advanced biliary tract cancer.
Journal: Innovation (Cambridge (Mass.))
Published: January 18, 2022
Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
Journal: Journal of clinical laboratory analysis
Published: March 11, 2021
Identification and validation of cetuximab resistance associated long noncoding RNA biomarkers in metastatic colorectal cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 30, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026